v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net loss $ (962,000) $ (912,000)
Adjustments to reconcile net loss to net cash from operating activities:    
Depreciation, amortization, and other 1,294,000 1,449,000
Accretion of debt issuance costs 21,000 24,000
Non cash lease expense 133,000 157,000
Accretion of unfavorable lease position (5,000) (26,000)
Stock-based compensation expense 101,000 89,000
Changes in operating assets and liabilities:    
Receivables 1,003,000 2,127,000
Prepaid expenses and other assets (29,000) 576,000
Accounts payable and accrued liabilities 400,000 (883,000)
Related party liabilities 319,000 59,000
Lease liabilities (126,000) (157,000)
Net cash provided by operating activities 2,149,000 2,503,000
Investing activities:    
Payment for purchases of property and equipment (41,000) (4,015,000)
Net cash used in investing activities (41,000) (4,015,000)
Financing activities:    
Principal payments on long-term debt (472,000) (280,000)
Advances on line of credit 0 2,000,000
Capital contribution non-controlling interests 0 8,000
Distributions to non-controlling interests (125,000) 0
Net cash (used in) provided by financing activities (597,000) 1,728,000
Net change in cash, cash equivalents, and restricted cash 1,511,000 216,000
Cash, cash equivalents, and restricted cash at beginning of period 3,712,000 11,275,000
Cash, cash equivalents, and restricted cash at end of period 5,223,000 11,491,000
Supplemental cash flow disclosure    
Interest 257,000 409,000
Income tax (refunds) (316,000) 129,000
Schedule of non-cash investing and financing activities    
Equipment included in accounts payable and accrued liabilities 400,000 2,160,000
Detail of cash, cash equivalents and restricted cash at end of period    
Cash and cash equivalents 4,973,000 11,241,000
Restricted cash 250,000 250,000
Cash, cash equivalents, and restricted cash at end of period $ 5,223,000 $ 11,491,000